Croda Pharma brings 2 presentations to BPI 2026 in Boston, and exhibits at Booth 807. Its sessions focus on excipients in biologics. One covers formulation strategies that improve biologic stability, and another ties high-purity excipients to consistent bioprocessing outcomes.
| Organization | BPI 2026 Attendance |
|---|---|
Croda Pharma Snaith, United Kingdom | 1 Applications Scientist · 1 Research and Technology Manager |
Develops excipients and supplies high-purity materials for pharmaceutical formulations, including adjuvant systems and small molecule, protein and nucleic acid delivery platforms. | Booth Exhibiting at Booth 807 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 1:00pm–1:45pm Biologic Stability Enhancement: Formulation Strategies and Excipients Downstream Processing Talk Fri Sep 25 12:15pm–12:45pm |
Instantly find 20 buyers from Croda Pharma
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction